Search Results
ECCO 2017 - A New PARP Inhibitor to Clinical Practice - Part 4
ECCO 2017 - A New PARP Inhibitor to Clinical Practice - Part 5
ECCO 2017 - A New PARP Inhibitor to Clinical Practice - Part 3
ECCO 2017 - A New PARP Inhibitor to Clinical Practice - Part 1
ECCO 2017 - A New PARP Inhibitor to Clinical Practice - Part 2
Innovations in ovarian cancer treatment: PARP inhibitors
Can PARP inhibitors offer benefit for all patients with platinum-sensitive ovarian cancer?
PARP inhibitors as first-line maintenance therapy in ovarian cancer
Maximizing the potential of PARP inhibitors as first-line maintenance therapy in ovarian cancer
Update on PARP inhibitors in Ovarian and Pancreatic Cancer
Niraparib Maintenance Therapy in Ovarian Cancer
Ovarian Cancer Australia Symposium 2016 Professor Jonathan Lederman on PARP Inhibitors.
